Nice to see that there is no pumping of ALA, just nice steady accumulation. The impatient starting to hit the sells, as nobody seems to be selling down. All good signs, imo.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%